121 related articles for article (PubMed ID: 15591767)
1. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways.
Chow LH; Huang EY; Ho ST; Tsai SK; Tao PL
J Biomed Sci; 2004; 11(6):717-25. PubMed ID: 15591767
[TBL] [Abstract][Full Text] [Related]
2. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
3. A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic.
Svokos K; Nalwalk JW; Leurs R; Menge WM; Timmerman H; Hough LB
Brain Res; 2001 Dec; 923(1-2):12-9. PubMed ID: 11743967
[TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats.
Hoffmann O; Wiesenfeld-Hallin Z
Neuroreport; 1996 Feb; 7(3):838-40. PubMed ID: 8733757
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
[TBL] [Abstract][Full Text] [Related]
8. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
Dogrul A; Seyrek M
Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
[TBL] [Abstract][Full Text] [Related]
9. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation.
Peiró AM; Climent L; Zapater P; Horga A; Horga JF
Pharmacol Res; 2011 Jul; 64(1):80-4. PubMed ID: 21420495
[TBL] [Abstract][Full Text] [Related]
11. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
12. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
14. Serotonin contributes to the spinal antinociceptive effects of morphine.
Crisp T; Stafinsky JL; Uram M; Perni VC; Weaver MF; Spanos LJ
Pharmacol Biochem Behav; 1991 Jul; 39(3):591-5. PubMed ID: 1686100
[TBL] [Abstract][Full Text] [Related]
15. Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception.
Roerig SC
Ann N Y Acad Sci; 2003 Dec; 1009():116-26. PubMed ID: 15028575
[TBL] [Abstract][Full Text] [Related]
16. Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors.
Kimura M; Obata H; Saito S
Anesthesiology; 2014 Aug; 121(2):362-71. PubMed ID: 24887968
[TBL] [Abstract][Full Text] [Related]
17. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
18. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
Bulka A; Wiesenfeld-Hallin Z; Xu XJ
Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
[TBL] [Abstract][Full Text] [Related]
19. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
Huang EY; Liu TC; Tao PL
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):386-92. PubMed ID: 14564449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
